Insider Cluster (2 insiders) ·Filed Jun 11, 2026

ANIP

ANI PHARMACEUTICALS INC
NEUTRAL
Impact 3/10
Horizonweeks Processed3mo ago
Insider cluster: 2 insiders, $427K total
Actionable Insight • Neutral

Insider selling is immaterial both in dollar terms and as a fraction of market cap. The CFO's sale is a same-day exercise-and-sell (code M + code S), a non-informative pattern common to scheduled option expirations. No bearish signal — treat as routine portfolio management.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
ANIP ▼ -12.76% at T+60d
NEUTRAL call ✗ call lost -12.76% · α vs SPY -17.16% · entry $81.65 → $71.23
Entry anchored
Jun 10, 03:59 PM ET
via exchange tick
T+1d
+0.04%
call +0.04% · α -0.50%
$81.68
settled 4mo ago
T+5d
-1.38%
call -1.38% · α -1.82%
$80.52
settled 4mo ago
T+20d
+2.61%
call +2.61% · α +0.72%
$83.78
settled 3mo ago
T+60d
-12.76%
call -12.76% · α -17.16%
$71.23
settled 28d ago

Price Chart

Loading chart...

Executive Summary

CFO Stephen Carey exercised and sold option shares in a same-day cashless transaction on June 5, and a director sold a smaller block on June 8. Total open-market sales of ~$427K represent ~0.024% of ANIP's $1.8B market cap, well below the 0.1% threshold for materiality. The CFO's sale is routine tax- and exercise-related selling, not an unusual bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$427.0K
Insiders
2

Key Facts

  • CFO Carey exercised 3,312 options at $49.51 and sold the same day at $80, netting ~$265K cash
  • Director Thomas sold 2,000 shares at $80.88 for ~$162K
  • Total cluster open-market sales: ~$427K — 0.024% of $1.8B market cap
  • CFO's sell transaction is a same-day exercise-and-sell (cashless), routine for tax/expiration management
  • No unexercised options or stock grants were retained — entire exercise was monetized

Financial Impact

Insiders sold ~$427K in open-market sales, negligible relative to $1.8B market cap

insider ownershipliquidity

Risk Factors

  • None from cluster alone — no material insider divestiture pattern
  • Historical calibration shows this report type has limited predictive power for ANIP

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (14 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ANIP-1781140055008
21 reports for ANIP
Performance horizon
43% Hit rate 3 of 7 directional calls best @ T+60▲ +8.88%Apr 8, 2026
Filters
Rows
Reports for ANIP — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
NEUTRAL ★ 2/10
$72.11 $77.91▲ +8.04%▲ +7.23%$71.97 (−0.19%)
Sep 1, 2026
4w ago
Insider Cluster
NEUTRAL ★ 3/10
$73.06 $71.46▼ −2.19%▼ −1.23%$71.97 (−1.49%)
Aug 24, 2026
5w ago
8-K
NEUTRAL ★ 2/10
$74.17 $73.25▼ −1.24%▼ −1.71%$71.97 (−2.97%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$74.77 $77.32▲ +3.41%▲ +5.37%$71.97 (−3.74%)
Aug 7, 2026
8w ago
8-K
BULLISH ★ 6/10
$78.25 $76.54▼ −2.19%▼ −2.58%$71.97 (−8.03%)
Jul 16, 2026
11w ago
Court Ruling
NEUTRAL ★ 2/10
$81.92 $78.53▼ −4.14%▼ −2.47%$71.97 (−12.15%)
Jul 13, 2026
11w ago
Press Release
BULLISH ★ 6/10
$81.08 $79.20▼ −2.32%▼ −1.53%$71.97 (−11.24%)
Jun 15, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$83.00 $82.94▼ −0.07%▲ +2.16%$71.97 (−13.29%)
Jun 11, 2026
16w ago
Insider Cluster
NEUTRAL ★ 3/10
$81.65 $80.52▼ −1.38%▼ −1.82%$71.97 (−11.86%)
May 21, 2026
19w ago
8-K
NEUTRAL ★ 3/10
$82.72 $76.71▼ −7.27%▼ −8.92%$71.97 (−13.00%)
Showing 10 of 21

US Market Status

Market Open — Closes in 2h 17m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 11, 2026